ArticleAnais brasileiros de dermatologia

Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?

Emek Kocatürk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.